Drugmakers wary of bill on comparative studies

03/31/2008 | Forbes

Drug and device companies are worried proposed legislation to fund independent comparative studies of specific treatments would drive insurance coverage and threaten sales. Industry players are particularly concerned such research would prioritize cost-effectiveness over product efficacy.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY